Validation of a new high-performance liquid chromatography assay for nizatidine

Therapeutic Drug Monitoring

Volumn 28, Issue 2, 2006, Pages 232-236

  Yusuf, Ahmed ^a   Dgither, Saleh Al ^a   Hammami, Muhammad M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Bioavailability; Bioequivalence; High performance liquid chromatography; Nizatidine; Pharmacokinetics

Indexed keywords

4 AMINOPHENAZONE; ACETONITRILE; DISODIUM HYDROGEN PHOSPHATE; METHANOL; NIZATIDINE; TRIETHYLAMINE;

ARTICLE; CALIBRATION; DRUG STABILITY; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SPECTROPHOTOMETRY; VALIDATION STUDY;

AMPYRONE; ANTIPYRINE; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; NIZATIDINE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 33748179739     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000189902.08684.90     Document Type: Article

References (19)

1. Hutchinson TA, Shahan DR, eds. DRUGDEX® System. Greenwood Village, Colorado: Thomson MICROMEDEX, (edition expires 3/2003).
2. Tracqui A, Kintz P, Mangin P. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography. J Chromatogr Biomed Appl. 1990;529:369-376.
3. Minic D, Petkovic J, Koricanac Z, et al. Spectrophotometric determination of nizatidine in pharmaceutical preparations. J Pharm Biomed Anal. 1996;14:1355-1358.
4. Vladimirov S, Brboric J, Svonja M, et al. Spectrophotometric determination of nizatidine in pharmaceutical formulations. J Pharm Biomed Anal. 1995;13:933-936.
5. Koricanac Z, Jovanovic T, Stankovic B. Determination of nizatidine in pharmaceutical formulations by potentiometric titration. Pharmazie. 1995;50:151.
6. Nikolic K, Bogavac M, Stankovic B. Coulometric determination of nizatidine. J Pharm Biomed Anal. 1995;13:683-685.
7. Kapetanovic V, Milovanovic L, Valadimirov S. Differential pulse polarographic determination of nizatidine in pharmaceutical formulations. Farmaco. 1994;49:377-379.
8. Hassan EM, Belal F. Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations. J Pharm Biomed Anal. 2002;27:31-38.
9. Walash MI, Belal F, Ibrahim F, et al. Kinetic spectrophotometric method for the determination of ranitidine and nizatidine in pharmaceuticals. J AOAC Int. 2002;85:1316-1323.
10. Wu SM, Ho YH, Wu HL, et al. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis. Electrophoresis. 2001;22:2758-2762.
11. Ho C, Huang HM, Hsu SY, et al. Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products. Drug Dev Ind Pharm. 1999;25:379-385.
12. Carlucci G. High-performance liquid chromatographic assay for nizatidine. A new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns. J Chromatogr A. 1990;525:490-494.
13. Knadler MP, Bergstrom RF, Callaghan JT, et al. Nizatidine, an H2-blocker. Its metabolism and disposition in man. Drug Metab Dispos. 1986;14:175-182.
14. Wu SM, Ho YH, Wu HL, et al. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma. Electrophoresis. 2001;22:2717-2722.
15. Abdel-Rahman SM, Johnson FK, Manowitz N, et al. Single-dose pharmacokinetics of nizatidine (Axid) in children. J Clin Pharmacol. 2002;42:1089-1096.
16. Abdel-Rahman SM, Johnson FK, Gauthier-Dubois G, et al. The bioequivalence of nizatidine (Axid) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule. J Clin Pharmacol. 2003;43:148-153.
17. Blum RA, Braverman AJ, Rice P, et al. Pharmacokinetics and pharmacodynamics of a novel nizatidine controlled-release formulation in healthy subjects. J Clin Pharmacol. 2003;43:74-83.
18. Sullivan TJ, James HR, Bachmann KA, et al. Bioavailability study of nizatidine when administered in food. Am J Ther. 1995;275-278.
19. Al-Majed AA, Belal F, Al-Obaid AM, et al. The voltametric behavior of nizatidine and its determination in biological fluids. J Pharm Biomed Anal. 1999;21:319-326.